Envelope diversity, characteristics of V3 region and predicted co-receptor usage of human immunodeficiency viruses infecting north indians

Journal of Microbiology

Volumn 50, Issue 5, 2012, Pages 869-873

  Andrabi, Raiees ^a   Kumar, Rajesh ^a   Bala, Manju ^b   Nair, Ambili ^a   SS, Prakash ^a   Kushwaha, Vandana ^a   Luthra, Kalpana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

co receptor usage; envelope glycoprotein; HIV 1; subtypes; variable regions

Indexed keywords

EID: 84868574106     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-012-2136-z     Document Type: Article

References (19)

1. Andrabi, R., Choudhary, A. K., Bala, M., Kalra, R., Prakash, S. S., andey, R. M., and Luthra, K. 2011. Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence. Arch. Virol. 156, 1787-1794.
2. Berger, E. A., Murphy, P. M., and Farber, J. M. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700.
3. Cecilia, D., Kulkarni, S. S., Tripathy, S. P., Gangakhedkar, R. R., Paranjape, R. S., and Gadkari, D. A. 2000. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology271, 253-258.
4. Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., andet al. 2002. Diversity considerations in HIV-1 vaccine selection. Science296, 2354-2360.
5. Gharu, L., Ringe, R., Pandey, S., Paranjape, R., and Bhattacharya, J. 2009. HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop. Virus Res. 144, 306-314.
6. Hemelaar, J., Gouws, E., Ghys, P. D., and Osmanov, S. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS20, W13-23.
7. John, T. J., Babu, P. G., Jayakumari, H., and Simoes, E. A. 1987. Prevalence of HIV infection in risk groups in Tamilnadu, India. Lancet1, 160-161.
8. Korber, B. T., MacInnes, K., Smith, R. F., and Myers, G. 1994. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J. Virol. 68, 6730-6744.
9. Lakhashe, S., Thakar, M., Godbole, S., Tripathy, S., and Paranjape, R. 2008. HIV infection in India: epidemiology, molecular epidemiology and pathogenesis. J. Biosci. 33, 515-525.
10. Lynch, R. M., Rong, R., Li, B., Shen, T., Honnen, W., Mulenga, J., Allen, S., Pinter, A., Gnanakaran, S., and Derdeyn, C. A. 2010. Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection. Virology404, 59-70.
11. Modrow, S., Hahn, B. H., Shaw, G. M., Gallo, R. C., Wong-Staal, F., and Wolf, H. 1987. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61, 570-578.
12. Ndung'u, T., Sepako, E., McLane, M. F., Chand, F., Bedi, K., Gaseitsiwe, S., Doualla-Bell, F., Peter, T., Thior, I., Moyo, S. M., andet al. 2006. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology347, 247-260.
13. Neogi, U., Sood, V., Chowdhury, A., Das, S., Ramachandran, V. G., Sreedhar, V. K., Wanchu, A., Ghosh, N., and Banerjea, A. C. 2009. Genetic analysis of HIV-1 circulating recombinant form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage. AIDS Res. Ther. 6, 28.
14. Pantophlet, R. and Burton, D. R. 2006. GP120: target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 24, 739-769.
15. Patel, M. B., Hoffman, N. G., and Swanstrom, R. 2008. Subtype-pecific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins. J. Virol. 82, 903-916.
16. Richman, D. D. and Bozzette, S. A. 1994. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169, 968-974.
17. Shankarappa, R., Chatterjee, R., Learn, G. H., Neogi, D., Ding, M., Roy, P., Ghosh, A., Kingsley, L., Harrison, L., Mullins, J. I., andet al. 2001. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol. 75, 10479-10487.
18. Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., and Hammer, S. M. 2008. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358, 1590-1602.
19. Zhang, H., Tully, D. C., Zhang, T., Moriyama, H., Thompson, J., and Wood, C. 2010. Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4. Virology407, 68-79.